These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2511098)

  • 61. The ribs in thalassemia. I. The relationship to therapy.
    Lawson JP; Ablow RC; Pearson HA
    Radiology; 1981 Sep; 140(3):663-72. PubMed ID: 7280233
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The use of microaggregate filtration in the prevention of febrile transfusion reactions.
    Schned AR; Silver H
    Transfusion; 1981; 21(6):675-81. PubMed ID: 7314215
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical efficacy of five filters specific for leukocyte removal.
    Reverberi R; Menini C
    Vox Sang; 1990; 58(3):188-91. PubMed ID: 2339527
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Colloid clearance rate changes in children with homozygous-beta-thalassemia in relation to blood transfusion.
    Dimitriou PA; Karpathios TE; Antipas SE; Fretzayias AM; Kasfiki AG; Melissinos KG; Matsaniotis NS
    Eur J Nucl Med; 1980 Oct; 5(5):427-30. PubMed ID: 7215364
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevention of febrile nonhemolytic and allergic transfusion reactions with pretransfusion medication: is this evidence-based medicine?
    Tobian AA; King KE; Ness PM
    Transfusion; 2008 Nov; 48(11):2274-6. PubMed ID: 19054374
    [No Abstract]   [Full Text] [Related]  

  • 66. Preparation of granulocyte-poor red blood cells by microaggregate filtration: a simplified method to minimize febrile transfusion reactions.
    Wenz B; Gurtlinger KF; O'Toole AM; Dugan EP
    Vox Sang; 1980 Nov; 39(5):282-7. PubMed ID: 7257237
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Microaggregate-poor blood used as leukocyte-poor blood].
    Skottun T; Jørgensen J
    Ugeskr Laeger; 1984 Sep; 146(37):2780-1. PubMed ID: 6515899
    [No Abstract]   [Full Text] [Related]  

  • 68. Blood transfusion in Bangladesh with particular emphasis on the treatment of Thalassemia patients.
    Islam MB
    Transfus Apher Sci; 2013 Aug; 49(1):3-4. PubMed ID: 23916541
    [No Abstract]   [Full Text] [Related]  

  • 69. Febrile transfusion reactions reduced by use of buffy-coat-poor erythrocyte concentrates.
    Liedén G; Hildén JO
    Vox Sang; 1982 Nov; 43(5):263-5. PubMed ID: 7147860
    [No Abstract]   [Full Text] [Related]  

  • 70. [Erythrocyte transfusion].
    Yuasa S
    Nihon Rinsho; 1977 Dec; 35(12):4111-6. PubMed ID: 606866
    [No Abstract]   [Full Text] [Related]  

  • 71. Leukocyte-poor red cells and transfusion reactions.
    Kasprisin DO
    Transfusion; 1981; 21(2):227. PubMed ID: 7222206
    [No Abstract]   [Full Text] [Related]  

  • 72. Transfusion of patients with leucocyte antibodies using cotton wool filtered blood.
    Major KE; Child JA; Roberts BE
    J Clin Pathol; 1981 Feb; 34(2):225. PubMed ID: 7229106
    [No Abstract]   [Full Text] [Related]  

  • 73. Transfusion complications in thalassemias.
    Ambruso DR
    Transfusion; 2014 Apr; 54(4):957-9. PubMed ID: 24724786
    [No Abstract]   [Full Text] [Related]  

  • 74. Problems of leucocyte transfusions.
    BRECHER G; CRONKITE EP; BOND VP; DUTCHER TF
    Acta Haematol; 1958; 20(1-4):179-84. PubMed ID: 13582560
    [No Abstract]   [Full Text] [Related]  

  • 75. Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactions.
    Martí-Carvajal AJ; Solà I; González LE; Leon de Gonzalez G; Rodriguez-Malagon N
    Cochrane Database Syst Rev; 2010 Jun; 2010(6):CD007539. PubMed ID: 20556779
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prevention of non-hemolytic transfusion reactions with leucocyte-poor blood: a prospective study.
    Reverberi R; Ferrari L; Gennari M; Menini C
    Haematologica; 1989; 74(3):283-8. PubMed ID: 2511098
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A prospective study on the use of leucocyte-filters in reducing blood transfusion reactions in multi-transfused thalassemic children.
    Tan KK; Lee WS; Liaw LC; Oh A
    Singapore Med J; 1993 Apr; 34(2):109-11. PubMed ID: 8266145
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of filtration in the provision of leukocyte poor red cells to multitransfused patients.
    James J; Matthews RN; Holdsworth RF; Fulton A; Tauro GP; Hussein S; McGrath KM
    Pathology; 1986 Jan; 18(1):127-30. PubMed ID: 3725421
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A multistate cluster of red blood cell transfusion reactions associated with use of a leucocyte reduction filter.
    Alvarado-Ramy F; Kuehnert MJ; Alonso-Echanove J; Sledge L; Haley NR; Epstein J; Vostal J; Pearson M
    Transfus Med; 2006 Feb; 16(1):41-8. PubMed ID: 16480438
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Leukocyte-poor blood.
    Wenz B
    Crit Rev Clin Lab Sci; 1986; 24(1):1-20. PubMed ID: 3539518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.